alpha-Pyrrolidinononanophenone

DB05531InvestigationalSmall molecule

Investigated for use/treatment in actinic keratosis, breast cancer, liver cancer, melanoma, psoriasis and psoriatic disorders, and solid tumors.

Mechanism: Pharmacologically active on Stimulator of interferon genes protein
Curator reviewed
Primary indication: Investigated for use/treatment in actinic keratosis, breast cancer, liver cancer, melanoma, psoriasis and psoriatic disorders, and solid tumors.Curator reviewed
Formula / weight: C₁₉H₂₉NO · 287.447 g/mol (avg)
Also known as: alpha-Pnp
Code names: PV-10

Resolves to

Compound

Structure

InChIKeyRYJXAZXFWIWTOJ-UHFFFAOYSA-NSMILESCCCCCCCC(N1CCCC1)C(=O)C1=CC=CC=C1

Targets

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with alpha-Pyrrolidinononanophenone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.